Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126810371 | 12681037 | 1 | I | 201510 | 20151022 | 20160824 | 20160824 | PER | US-FRI-1000080480 | FOREST | 34.00 | YR | M | Y | 0.00000 | 20160824 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126810371 | 12681037 | 1 | PS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 20MG | 21323 | 20 | MG | QD | |||||||
| 126810371 | 12681037 | 2 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126810371 | 12681037 | 1 | Obsessive-compulsive disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126810371 | 12681037 | Disturbance in attention | |
| 126810371 | 12681037 | Drug ineffective | |
| 126810371 | 12681037 | Headache | |
| 126810371 | 12681037 | Malaise | |
| 126810371 | 12681037 | Off label use | |
| 126810371 | 12681037 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |